Search

Search Constraints

You searched for: Author/Creator Thompson, Ian M.

Search Results

1. A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancer. Issue 2 (March 2021)

2. A genome‐wide association study of prostate cancer in Latinos. Issue 7 (3rd July 2019)

3. A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. Issue 11 (4th May 2015)

4. Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate Cancer. Issue 2 (28th August 2022)

5. Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate Cancer. Issue 2 (28th August 2022)

6. Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate Cancer. Issue 2 (28th August 2022)

7. Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate Cancer. Issue 2 (28th August 2022)

8. Adding genetic risk score to family history identifies twice as many high‐risk men for prostate cancer: Results from the prostate cancer prevention trial. Issue 12 (16th May 2016)

9. African‐specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer. Issue 1 (24th September 2020)

10. Age‐related macular degeneration in a randomized trial of selenium and vitamin E in men: the Select Eye Endpoints (SEE) study (SWOG S0000B). Issue 2 (23rd July 2020)